Europe Diabetic Retinopathy Market Size & Outlook, 2025-2030
The diabetic retinopathy market in Europe is expected to reach a projected revenue of US$ 3,938.7 million by 2030. A compound annual growth rate of 6.3% is expected of Europe diabetic retinopathy market from 2025 to 2030.
Revenue, 2024 (US$M)
$2,732.9
Forecast, 2030 (US$M)
$3,938.7
CAGR, 2025 - 2030
6.3%
Report Coverage
Europe
Global Market
Related Markets
Europe diabetic retinopathy market highlights
- The Europe diabetic retinopathy market generated a revenue of USD 2,732.9 million in 2024.
- The market is expected to grow at a CAGR of 6.3% from 2025 to 2030.
- In terms of segment, non-proliferative diabetic retinopathy was the largest revenue generating types in 2024.
- Proliferative Diabetic Retinopathy is the most lucrative types segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2025 to 2030.
Europe data book summary
| Market revenue in 2024 | USD 2,732.9 million |
| Market revenue in 2030 | USD 3,938.7 million |
| Growth rate | 6.3% (CAGR from 2025 to 2030) |
| Largest segment | Non-proliferative diabetic retinopathy |
| Fastest growing segment | Proliferative Diabetic Retinopathy |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Proliferative Diabetic Retinopathy, Non-proliferative diabetic retinopathy |
Other key industry trends
- In terms of revenue, Europe region accounted for 28.8% of the global diabetic retinopathy market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,978.1 million by 2030.
No credit card required*
Publish Date: Nov 12, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Diabetic Retinopathy Market Scope
Diabetic Retinopathy Market segmentation & scope
Diabetic Retinopathy Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| AbbVie Inc | View profile | 50,000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | www.abbvieinvestor.com |
| Bayer AG | View profile | 99,723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | www.bayer.com |
| Genentech | View profile | 10001+ | South San Francisco, California, United States, North America | gene.com |
| Kowa Company Ltd. | View profile | - | - | - |
| Oxurion | View profile | 51-100 | Heverlee, Vlaams-Brabant, Belgium, Europe | www.oxurion.com |
| Sirnaomics | View profile | 51-100 | Gaithersburg, Maryland, United States, North America | www.sirnaomics.com |
| Alimera Sciences | View profile | 51-100 | Alpharetta, Georgia, United States, North America | www.alimerasciences.com |
| Ampio Pharmaceuticals | View profile | 11-50 | Greenwood Village, Colorado, United States, North America | ampiopharma.com |
| BCN PEPTIDES | View profile | 11-50 | Mediona, Catalonia, Spain, Europe | www.bcnpeptides.com |
Europe Diabetic Retinopathy Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Diabetic Retinopathy Market Outlook will help companies and investors design strategic landscapes.
Non-Proliferative Diabetic Retinopathy was the largest segment with a revenue share of 74.03% in 2024.
Horizon Databook has segmented the Europe diabetic retinopathy market based on proliferative diabetic retinopathy, non-proliferative diabetic retinopathy covering the revenue growth of each sub-segment from 2018 to 2030.
- Europe Diabetic Retinopathy Market Types Outlook (Revenue, USD Million , 2018-2030)
- Proliferative Diabetic Retinopathy
- Non-proliferative diabetic retinopathy
- Europe Diabetic Retinopathy Market Management Outlook (Revenue, USD Million , 2018-2030)
- Anti-VEGF
- Intraocular Steroid Injection
- Laser Surgery
- Vitrectomy
Reasons to subscribe to Diabetic Retinopathy Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Diabetic Retinopathy Market Outlook databook
- Our clientele includes a mix of Diabetic Retinopathy Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Diabetic Retinopathy Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Diabetic Retinopathy Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Europe Diabetic Retinopathy Market, 2018-2030 (US$M)
Europe diabetic retinopathy market statistics, by types, 2018-2030 (US$M)
